Publications
- The association of taxane resistance genes with the clinical course of ovarian carcinoma2013 | First Faculty of Medicine, Second Faculty of Medicine
- High-dose density neoadjuvant chemotherapy in bulky IB cervical cancer2013 | Second Faculty of Medicine
- Konsolidation chemotherapy in ovarian cancer - kontroversies.2003 | Central Library of Charles University
- Serum hCG positivity regression in different molar pregnancies: clinical trends and prognosis2001 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Physical Education and Sport
- Current Possibilities and Trends in the Chemotherapy - Epithelial Ovarian Malignant Tumours1999 | Central Library of Charles University
- Antiemetic treatment during cisplatinum chemotherapy (ondansetron versus granisetron)1998 | Publication without faculty affiliation
- Neoadjuvant chemotherapy in patient with primary unresectable ovarian cancerPublication without faculty affiliation
- Safety and efficacy of dendritic cell-based immunotherapy DCVAC/OvCa added to first-line chemotherapy (carboplatin plus paclitaxel) for epithelial ovarian cancer: a phase 2, open-label, multicenter, randomized trial2022 | First Faculty of Medicine, Second Faculty of Medicine, Central Library of Charles University, Third Faculty of Medicine, Faculty of Medicine in Pilsen
- Dendritic cell-based immunotherapy (DCVAC/OvCa) combined with second-line chemotherapy in platinum-sensitive ovarian cancer (SOV02): A randomized, open-label, phase 2 trial2021 | First Faculty of Medicine, Central Library of Charles University, Third Faculty of Medicine
- Live Birth Following Uterine Transplantation From a Nulliparous Deceased Donor2021 | First Faculty of Medicine, Second Faculty of Medicine
Loading network view...